Citius Pharmaceuticals, Inc. (CTXR)

Citius Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020
Cash & Equivalents	6.09	3.25	26.48	41.71	70.07	13.86
Cash & Short-Term Investments	6.09	3.25	26.48	41.71	70.07	13.86
Cash Growth	-66.00%	-87.72%	-36.51%	-40.47%	405.59%	75.58%
Inventory	17.21	8.27	-	-	-	-
Prepaid Expenses	1.31	2.7	7.89	2.85	2.74	0.12
Total Current Assets	24.61	14.22	34.37	44.56	72.81	13.98
Property, Plant & Equipment	0.88	0.25	0.46	0.65	0.83	0.99
Goodwill	9.35	9.35	9.35	9.35	9.35	9.35
Other Intangible Assets	92.8	92.8	59.4	59.4	59.4	19.4
Other Long-Term Assets	0.04	0.04	0.04	0.04	0.04	0.06
Total Assets	127.68	116.65	103.61	114	142.43	43.77
Accounts Payable	10.09	4.93	2.93	1.17	1.28	1.86
Accrued Expenses	12.23	2.25	2.63	3.17	2.53	1.91
Short-Term Debt	1	-	-	-	-	0.17
Current Portion of Leases	0.11	0.24	0.22	0.2	0.18	0.16
Other Current Liabilities	28.4	28.4	-	-	-	-
Total Current Liabilities	51.84	35.81	5.78	4.53	3.98	4.1
Long-Term Debt	-	-	-	-	-	0.16
Long-Term Leases	0.77	0.02	0.26	0.48	0.68	0.86
Long-Term Deferred Tax Liabilities	7.51	6.71	6.14	5.56	4.99	4.99
Total Liabilities	60.12	42.55	12.18	10.57	9.65	10.1
Common Stock	0.01	0.01	0.01	0.15	0.15	0.06
Additional Paid-In Capital	295.89	271.44	253.06	232.37	228.08	104.21
Retained Earnings	-230.84	-201.37	-162.23	-129.69	-96.05	-70.59
Total Common Equity	65.06	70.08	90.83	102.83	132.18	33.67
Minority Interest	2.5	4.02	0.6	0.6	0.6	-
Shareholders' Equity	67.56	74.1	91.43	103.43	132.78	33.67
Total Liabilities & Equity	127.68	116.65	103.61	114	142.43	43.77
Total Debt	1.88	0.26	0.48	0.68	0.86	1.35
Net Cash (Debt)	4.21	2.99	26	41.03	69.22	12.51
Net Cash Growth	-76.08%	-88.50%	-36.64%	-40.72%	453.40%	62.00%
Net Cash Per Share	0.49	0.44	4.30	7.02	15.93	7.98
Filing Date Shares Outstanding	17.01	7.73	6.36	5.85	5.84	2.22
Total Common Shares Outstanding	14.48	7.25	6.35	5.85	5.84	2.22
Working Capital	-27.23	-21.59	28.59	40.03	68.83	9.88
Book Value Per Share	4.49	9.67	14.29	17.58	22.64	15.15
Tangible Book Value	-37.09	-32.07	22.08	34.08	63.44	4.92
Tangible Book Value Per Share	-2.56	-4.43	3.48	5.83	10.86	2.21

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q